Home > Insider Trading > Filing (0001209191-17-061349)

Filing Details

Accession Number:: 0001209191-17-061349
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-11-16 20:22:34
Reporting Period:: 2017-11-14

Accepted Time:: 2017-11-16 20:22:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876378	Transenterix Inc.	TRXC	Surgical & Medical Instruments & Apparatus (3841)	112962080

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246530	P Joseph Slattery	C/O Transenterix, Inc. 635 Davis Drive, Suite 300 Morrisville NC 27560	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-11-14	333,000	$2.93	440,974	No	4	S	Direct
Common Stock	Disposition	2017-11-15	110,000	$2.59	330,974	No	4	S	Direct
Common Stock	Disposition	2017-11-16	86,609	$2.56	244,365	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,000	Indirect	By IRA

Footnotes

The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.67 to $3.15 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.655 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Represents sales of an equivalent number of shares purchased by the reporting person as a participant in TRXC's May 2017 public offering. Following the sales on November 14, November 15 and November 16, 2017, the reporting person continues to own 269,365 shares of the company's common stock. The reporting person also holds stock options to acquire 1,781,900 shares of common stock, of which approximately 53% are vested, and restricted stock units representing an additional 658,888 shares of common stock subject to forfeiture restrictions.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.645 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.